Rec. A.2: The DoD OIG recommended that the Assistant Secretary of Defense for Health Affairs, in coordination with the Defense Health Agency and the Service Surgeons General, develop a pharmaceutical oversight plan for the White House Medical Unit. At a minimum, the oversight plan should: a. Designate an organization to have oversight responsibility for the White House Medical Unit. b. Establish procedures the auditor should perform and written verification of corrective actions taken in response to auditor recommendations. c. Reconcile medication inventory counts, including disposition of controlled substance unit doses registered to the White House Medical Unit. d. Justify the purchase of brand name medications in writing, including the quantity. e. Designate the use of specific waste containers for medical disposal that comply with Federal and Service policy.